Therapeutic clinical applications of reactor-produced radioisotopes
- Oak Ridge National Lab., TN (United States)
One of the most rapidly growing areas of clinical nuclear medicine is the therapeutic use of radioisotopes for applications in oncology, rheumatology and, more recently, interventional cardiology. With the rapidly increasing development and evaluation of new agents, their introduction into clinical use, and commercialization, the availability of high levels of therapeutic reactor-produced neutron-rich radioisotopes is of increasing importance. The goals of this paper are to discuss the issues associated with optimization of the production and processing of reactor-produced radioisotopes for therapy, with special emphasis on {sup 188}W, and the optimization of the use of the {sup 188}W/{sup 188}Re generator. In addition, other key examples of therapeutic radioisotopes of current interest and their specific clinical applications are discussed.
- OSTI ID:
- 552701
- Report Number(s):
- CONF-971125-; ISSN 0003-018X; TRN: 98:001906
- Journal Information:
- Transactions of the American Nuclear Society, Vol. 77; Conference: 1997 American Nuclear Society (ANS) winter meeting, Albuquerque, NM (United States), 16-20 Nov 1997; Other Information: PBD: 1997
- Country of Publication:
- United States
- Language:
- English
Similar Records
Rhenium-188 Labeled Radiopharmaceuticals: Current Clinical Applications in Oncology and Promising Perspectives
Reactor production and processing of radioisotopes for therapeutic applications in nuclear medicine